Literature DB >> 15044632

Differential susceptibilities of murine hepatoma 1c1c7 and Tao cells to the lysosomal photosensitizer NPe6: influence of aryl hydrocarbon receptor on lysosomal fragility and protease contents.

Joseph A Caruso1, Patricia A Mathieu, Aby Joiakim, Brendan Leeson, David Kessel, Bonnie F Sloane, John J Reiners.   

Abstract

Irradiation of murine hepatoma 1c1c7 cultures presensitized with N-aspartyl chlorin e6 (NPe6) caused lysosomal disruption and apoptosis. Tao cells, a variant of the 1c1c7 line having lower aryl hydrocarbon receptor (AhR) contents, were resistant to the pro-apoptotic effects of NPe6 in the same photodynamic therapy protocol. Colony-forming assays were used to establish light dose-dependent and NPe6 concentration-dependent cytotoxicity curves. Lysosomal breakage and cell survival paralleled one another in both cell types. When analyzed at comparable lethal dose conditions, the onset of apoptosis was delayed, and the magnitude of the apoptotic response was muted in Tao cells, as assessed by morphology, annexin V binding, caspase-3 activities, and analyses of Bid, procaspase-9, and pro-caspase-3 cleavage. In contrast, the kinetics/magnitude of pro-caspase-3 activation in the two cell lines were identical after exposure to HA14 -1 or Jo2 antibody, inducers of the intrinsic and extrinsic apoptotic pathways, respectively. Tao endosomal/lysosomal extracts contained approximately 50%, 35%, and 55% of the Bid cleavage and cathepsin B and D activities of 1c1c7 endosomes/lysosomes, respectively. Western blot analyses confirmed reduced cathepsin B/D contents in Tao cells. Analyses of 1c1c7/Tao variants engineered to express antisense/sense AhR constructs suggested that endosomal/lysosomal cathepsin B and D content, but not whole cell content, correlated with AhR expression. These studies provide a mechanism for the resistance of Tao cultures to the proapoptotic effects of a protocol causing targeted disruption of lysosomes. They also suggest that the AhR, in the absence of exogenous ligand, may affect the trafficking/processing of proteases normally found in endosomes/lysosomes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044632     DOI: 10.1124/mol.65.4.1016

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  23 in total

1.  Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption.

Authors:  Tiancheng Liu; Lisa Y Wu; Clifford E Berkman
Journal:  Cancer Lett       Date:  2010-05-08       Impact factor: 8.679

2.  Nonesterified cholesterol content of lysosomes modulates susceptibility to oxidant-induced permeabilization.

Authors:  John J Reiners; Miriam Kleinman; David Kessel; Patricia A Mathieu; Joseph A Caruso
Journal:  Free Radic Biol Med       Date:  2010-11-11       Impact factor: 7.376

3.  In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivo.

Authors:  Ashley J Parks; Michael P Pollastri; Mark E Hahn; Elizabeth A Stanford; Olga Novikov; Diana G Franks; Sarah E Haigh; Supraja Narasimhan; Trent D Ashton; Timothy G Hopper; Dmytro Kozakov; Dimitri Beglov; Sandor Vajda; Jennifer J Schlezinger; David H Sherr
Journal:  Mol Pharmacol       Date:  2014-08-26       Impact factor: 4.436

4.  Photodynamic therapy combined with a cysteine proteinase inhibitor synergistically decrease VEGF production and promote tumour necrosis in a rat mammary carcinoma.

Authors:  B Zsebik; K Symonowicz; Y Saleh; P Ziolkowski; A Bronowicz; G Vereb
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

5.  Polymeric nucleic acid vehicles exploit active interorganelle trafficking mechanisms.

Authors:  Katye M Fichter; Nilesh P Ingle; Patrick M McLendon; Theresa M Reineke
Journal:  ACS Nano       Date:  2012-12-31       Impact factor: 15.881

6.  Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma.

Authors:  Anna Bianchi-Smiraglia; Archis Bagati; Emily E Fink; Hayley C Affronti; Brittany C Lipchick; Sudha Moparthy; Mark D Long; Spencer R Rosario; Shivana M Lightman; Kalyana Moparthy; David W Wolff; Dong Hyun Yun; Zhannan Han; Anthony Polechetti; Matthew V Roll; Ilya I Gitlin; Katerina I Leonova; Aryn M Rowsam; Eugene S Kandel; Andrei V Gudkov; P Leif Bergsagel; Kelvin P Lee; Dominic J Smiraglia; Mikhail A Nikiforov
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

Review 7.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

8.  Enhanced efficacy of photodynamic therapy via a sequential targeting protocol.

Authors:  David Kessel; John J Reiners
Journal:  Photochem Photobiol       Date:  2014-04-01       Impact factor: 3.421

9.  ATG7 deficiency suppresses apoptosis and cell death induced by lysosomal photodamage.

Authors:  David H Kessel; Michael Price; John J Reiners
Journal:  Autophagy       Date:  2012-08-14       Impact factor: 16.016

Review 10.  Regulation of apoptosis-associated lysosomal membrane permeabilization.

Authors:  Ann-Charlotte Johansson; Hanna Appelqvist; Cathrine Nilsson; Katarina Kågedal; Karin Roberg; Karin Ollinger
Journal:  Apoptosis       Date:  2010-05       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.